Ask AI
ProCE Banner Activity

ADA 2026 Obesity Capsule Summary: Translating Evidence Into Clinical Action

Conference Coverage
Slideset

This ADA 2026 Obesity Capsule Summary highlights 4 key obesity studies from ADA 2026 and translates the findings into practical, evidence-based insights for clinical care. The activity is designed to help healthcare professionals evaluate emerging data and consider how new evidence may inform individualized, long-term obesity management.

Released: June 16, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Target Audience

This activity is intended for primary care physicians, endocrinologists, obesity medicine specialists, NPs, PAs, and clinical pharmacists involved in the longitudinal management of people with obesity and related cardiometabolic comorbidities. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify emerging obesity evidence most likely to inform current and future clinical practice

  • Evaluate emerging obesity data based on study design, strength of evidence, and clinical relevance to determine its potential impact on patient care

  • Apply emerging clinical obesity data to individualized, long-term treatment strategies, considering patient risk profiles, comorbidities, response to therapy, and shared decision-making